Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986142 in Moderate to Severe Rheumatoid Arthritis
NCT02638948Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of BMS-986142 in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Feb 2016; status: completed.
02
Drugs
BMS-986142
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02638948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638948.